Precipio PE Ratio 2010-2024 | PRPO

Current and historical p/e ratio for Precipio (PRPO) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Precipio PE ratio as of February 06, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Precipio PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-02-07 6.65 0.00
2024-09-30 6.70 $-1.83 0.00
2024-06-30 5.19 $-2.45 0.00
2024-03-31 6.70 $-3.42 0.00
2023-12-31 6.50 $-4.56 0.00
2023-09-30 5.61 $-7.44 0.00
2023-06-30 7.80 $-9.20 0.00
2023-03-31 13.28 $-9.20 0.00
2022-12-31 11.03 $-10.60 0.00
2022-09-30 16.08 $-10.40 0.00
2022-06-30 21.20 $-9.20 0.00
2022-03-31 27.00 $-10.20 0.00
2021-12-31 31.60 $-7.80 0.00
2021-09-30 56.40 $-6.00 0.00
2021-06-30 72.60 $-8.60 0.00
2021-03-31 46.20 $-9.80 0.00
2020-12-31 41.40 $-23.80 0.00
2020-09-30 49.00 $-33.40 0.00
2020-06-30 28.40 $-35.40 0.00
2020-03-31 14.00 $-52.40 0.00
2019-12-31 41.00 $-46.40 0.00
2019-09-30 52.20 $-105.80 0.00
2019-06-30 67.60 $-150.58 0.00
2019-03-31 37.50 $-174.55 0.00
2018-12-31 46.20 $-305.88 0.00
2018-09-30 118.56 $-236.88 0.00
2018-06-30 110.34 $-593.70 0.00
2018-03-31 161.16 $-5,151.43 0.00
2017-12-31 360.00 $-5,640.81 0.00
2017-09-30 648.00 $-5,640.81 0.00
2017-06-30 2700.00 $-5,953.37 0.00
2017-03-31 6030.00 $-1,800.90 0.00
2016-12-31 2557.80 $-2,611.31 0.00
2016-09-30 2538.00 $-2,611.31 0.00
2016-06-30 4950.00 $-6,843.43 0.00
2016-03-31 5252.40 $-9,094.55 0.00
2015-12-31 9630.00 $-10,895.45 0.00
2015-09-30 8308.80 $-17,828.92 0.00
2015-06-30 15030.00 $-13,326.67 0.00
2015-03-31 12960.00 $-15,757.89 0.00
2014-12-31 18090.00 $-17,918.97 0.00
2014-09-30 33930.00 $-11,435.72 0.00
2014-06-30 33660.00 $-17,471.34 0.00
2014-03-31 41220.00 $-15,581.69 0.00
2013-12-31 49680.00 $-14,502.88 0.00
2013-09-30 41040.00 $-17,295.57 0.00
2013-06-30 43200.00 $-15,133.63 0.00
2013-03-31 43200.00 $-12,971.68 0.00
2012-12-31 65880.00 $-14,052.65 0.00
2012-09-30 102599.99 $-10,809.73 0.00
2012-06-30 97200.00 $-9,728.76 0.00
2012-03-31 129599.99 $-22,700.44 0.00
2011-12-31 139319.99 $-23,781.41 0.00
2011-09-30 139319.99 $-25,943.36 0.00
2011-06-30 188999.99 $-24,862.38 0.00
2011-03-31 95040.00 $-12,971.68 0.00
2010-12-31 71280.00 $-7,566.81 0.00
2010-09-30 43200.00 $-5,404.87 0.00
2010-06-30 52920.00 $-4,323.89 0.00
2010-03-31 92880.00 $-3,242.92 0.00
2009-12-31 74520.00 $-4,323.89 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.010B $0.015B
Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.872B 57.28
Tempus AI (TEM) United States $10.232B 0.00
Hims & Hers Health (HIMS) United States $8.842B 224.83
Inspire Medical Systems (INSP) United States $5.430B 169.35
IRhythm Technologies (IRTC) United States $3.397B 0.00
Privia Health (PRVA) United States $2.723B 226.90
Enovis (ENOV) United States $2.544B 16.95
Azenta (AZTA) United States $2.469B 114.98
Clover Health Investments (CLOV) United States $2.225B 0.00
Schrodinger (SDGR) United States $1.886B 0.00
Omnicell (OMCL) United States $1.826B 39.83
10x Genomics (TXG) United States $1.773B 0.00
Phreesia (PHR) United States $1.680B 0.00
Butterfly Network (BFLY) United States $0.937B 0.00
Talkspace (TALK) United States $0.608B 0.00
Standard BioTools (LAB) United States $0.529B 0.00
Fulgent Genetics (FLGT) United States $0.507B 0.00
TruBridge (TBRG) United States $0.380B 110.57
Nyxoah SA (NYXH) Belgium $0.369B 0.00
Health Catalyst (HCAT) United States $0.334B 0.00
Pulmonx (LUNG) United States $0.254B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.233B 0.00
American Well (AMWL) United States $0.176B 0.00
EUDA Health Holdings (EUDA) Singapore $0.104B 0.00
MDxHealth SA (MDXH) Belgium $0.087B 0.00
P3 Health Partners (PIII) United States $0.073B 0.00
CareCloud (CCLD) United States $0.066B 0.00
HeartBeam (BEAT) United States $0.065B 0.00
111 (YI) China $0.057B 0.00
Zepp Health (ZEPP) China $0.045B 0.00
Outset Medical (OM) United States $0.043B 0.00
SHL Telemedicine (SHLT) Israel $0.043B 0.00
Zhongchao (ZCMD) China $0.037B 0.00
Movano (MOVE) United States $0.035B 0.00
Bullfrog AI Holdings (BFRG) United States $0.022B 0.00
MSP Recovery (MSPR) United States $0.019B 0.00
Streamline Health Solutions (STRM) United States $0.016B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.016B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Syra Health (SYRA) United States $0.005B 0.00
Healthcare Triangle (HCTI) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00